Skip to content

Efficacy and Mechanisms of 10-Hz Temporal Interference Stimulation Targeting the Thalamocortical Network in Pediatric Prolonged Disorders of Consciousness

Efficacy and Mechanisms of 10-Hz Temporal Interference Stimulation Targeting the Thalamocortical Network in Pediatric Prolonged Disorders of Consciousness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126044
Enrollment
Unknown
Registered
2026-06-02
Start date
2026-06-07
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prolonged disorders of consciousness

Interventions

Experimental Group 1:Received 10 Hz DM-pf single-target true stimulation therapy + conventional rehabilitation therapy
Experimental Group 2:Received 10 Hz DLPFC single-target true stimulation therapy + conventional rehabilitation therapy
Experimental Group 3:Received 10 Hz DM-pf-DLPFC dual-target true stimulation therapy + conventional rehabilitation therapy
Control group:Receive Sham tTIs and conventional rehabilitation treatment

Sponsors

The Third Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Age >2 years and 28 days; 4. Stable vital signs. 5. Written informed consent voluntarily provided by the child’s legal guardians.

Exclusion criteria

Exclusion criteria: 1. Active intracranial hemorrhage or skull defect; 2. Ongoing progression of brain injury; 3. Status epilepticus or seizure occurrence within the past 1 week; 4. Focal brain lesions in the stimulation sites (frontal and parietal regions), as indicated by neuroimaging reports; 5. Persistent severe agitation precluding the placement of tACS, EEG, or fNIRS equipment; 6. Decompressive craniectomy without subsequent cranioplasty; 7. Presence of implanted electronic devices contraindicated for MRI or other imaging modalities; 8. Current or prior participation in other clinical trials that may interfere with the results of this study; 9. Refusal of participation by the patient’s legal guardians.

Design outcomes

Primary

MeasureTime frame
Coma Recovery Scale-Revised;

Secondary

MeasureTime frame
electroencephalogram;Functional Near-Infrared Spectroscopy;

Countries

China

Contacts

Public ContactDengna Zhu

The Third Affiliated Hospital of Zhengzhou University

zhudengna@126.com+86 138 3814 1626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026